No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2009 ASCO Annual Meeting I. This abstract does not include a full text component.

GlycoMimetics has granted Pfizer exclusive worldwide rights to develop and commercialize GMI-1070, a rationally designed glycomimetic inhibitor of E-, L- and P-selectin, for vaso-occlusive crisis ...

Edited by: Thomas W. Durso S.D. Rosen, C.R. Bertozzi, "The selectins and their ligands," Current Opinion in Cell Biology, 6:663-73, 1994. (Cited in more than 60 publications through April 1996) ...

Bioengineers have developed an implantable device that captures very pure samples of stem cells circulating in the blood. The device, a length of plastic tubing coated with proteins, could lead to ...